Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention

Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

The purpose of this study to determine whether statin pretreatment decrease myocardial infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

Inclusion Criteria:

• Presence of chest pain for more than 30 minutes but less than 12 hours after symptom onset
• ST segment elevation more than 1 mm in two or more contiguous leads or presumably a new onset left bundle branch blockage

Exclusion Criteria:

• Cardiogenic shock
• History of myocardial infarction
• Chronic liver disease
• Previous or current statin use